Robert Mueller To Testify Before House Committees After Being Subpoenaed - NPR

-

Comments

Post a Comment

Popular posts from this blog

Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield | European Journal of Human Genetics

-
Image
blood disease myeloma :: Article Creator Rare Blood Disease Innovations Address Unmet Needs, According To ASH Data Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition, with key research presented on immune thrombocytopenia, hemophilia, and multiple myeloma. Innovations in rare blood disorders took center stage at ASH 2024. Image Credit: shidlovski-stock.Adobe.Com Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition, with Sanofi highlighting 49 abstracts, including 9 oral presentations, featured at the conference in San Diego.1 Key research was presented on immune thrombocytopenia (ITP), hemophilia, and multiple myeloma (MM), among other disease states. With new findings related to approved and investigational therapies alike, the diverse portfolio demonstrates the e...
Read more

Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

-
Image
Medicare Open Enrollment ends December 7. The easy choice is to stay with all-in-one Medicare Advantage instead of switching to Traditional Medicare plus a supplement and drug plan. The hard one is whether to switch between Medicare Advantage plans, from a well-liked one to one accepted at a so-called top-10 hospital. Humana Gold Plus, a Medicare Advantage HMO, has served me well for five years. Hearing aids cost me only $10 after its $2,000 allowance. Routine doctor and dentist appointments and my medication cost nothing. But Humana Gold Plus is not accepted by Northwestern Memorial Hospital, the nearby hospital that US News & World Report ranks as the tenth best in the country, or by Northwestern Medicine physicians. My primary care physician is in an Advocate Medical Group. If I were hospitalized, it would be at Advocate Illinois Masonic Medical Center. If I had a serious illness, I’d see specialists in Advocate’s network. Illinois Masonic is not a second-rate hospital, and...
Read more

Non-invasive prenatal testing: a revolutionary journey in prenatal testing

-
Image
factor ix deficiency :: Article Creator Novo Nordisk Files Long-acting Factor IX For Haemophilia B In US Novo Nordisk has filed its long-acting factor IX, nonacog beta pegol in the US for haemophilia B. Nonacog beta pegol is a glycopegylated recombinant factor IX with a longer half-life, developed for patients with haemophilia B. Novo said that the drug's half-life is five times longer than standard factor IX products, meaning fewer injections are needed. Although Novo has long had a presence in haemophilia, it faces competition in both haemophilia A and B. In haemophilia B, Biogen and Swedish Orphan Biovitrum have Alprolix (coagulation factor IX (recombinant)) approved in the EU and the US. The filing of nonacog beta pegol is based on the results from the PARADIGM clinical trial programme which involved 115 patients with severe or moderately severe haemophilia B. Nonacog beta pegol was found to be efficacious in routine prophylaxis, treat...
Read more